Tariffs and Supply Issues Hit Mission Produce (AVO) Share Price Despite Earnings Beat
Shares of leading avocado producer Mission Produce (AVO) witnessed a decline of over 12% in the past few days despite reporting strong Q1 2025 ...
Investing Snacks1d
Rep. Jefferson Shreve Makes Big Moves in Health Stocks
Rep. Jefferson Shreve recently purchased shares of Elevance Health valued between $15,001 and $50,000. The disclosure, filed on March 9, also revealed additional investments in major companies, ...
Clinical Trials Arena on MSN1d
Trevi’s Phase IIb chronic cough success spikes stock by 71%
The company’s trial of Haduvio met its primary and secondary endpoints in reducing coughing fits across patients by 53%.
Trevi Therapeutics price target raised to $12.50 from $7.50 at H.C. Wainwright
H.C. Wainwright analyst Oren Livnat raised the firm’s price target on Trevi Therapeutics (TRVI) to $12.50 from $7.50 and keeps a Buy rating on ...
Trevi Therapeutics Reveals Positive Data From Mid-Stage Study For Chronic Cough Candidate, Stock Jumps
Trevi's Haduvio met the primary endpoint in a Phase 2a trial, showing a significant reduction in cough frequency with no serious adverse events reported.
Gold Reserve makes stalking horse bid for Citgo parent shares
Gold Reserve (OTCQX:GDRZF) said Monday its Dalinar Energy subsidiary submitted an offer that could be chosen as the starting ...
Great-West Lifeco: Thriving Today, But Priced For Tomorrow (Rating Downgrade)
Great-West Lifeco's current valuation at 1.9x book value and forward P/E suggests limited upside potential. Explore more ...